基本信息
浏览量:6
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
He received the American Pediatric Society/Society for Pediatric Research National Young Investigator Award in 2002; and is an active member of the American Society for Clinical Investigation and the American Pediatric Society.
RESEARCH
The Scharenberg laboratory is focused on the development of technology for engineering T-cells and hematopoetic stem cells:
1. Gene editing methods and technology: Our present efforts are centered on optimizing gene editing efficiency in primary T-cells and hematopoietic stem cells using viral vectors and advanced electroporation methods, and on developing gene edited cell products for hematopoietic genetic diseases and tolerance applications.
2. Synthetic biology: Next generation cell therapies require new approaches to provide physician control over cell survival, expansion, and potency. We are working on developing orthogonal receptor signaling systems that can be embedded in gene edited cell products to enable precise control over these characteristics.
3. Vector biology: we are working on developing synthetic vector systems for delivery of gene therapy and gene editing components both ex vivo and in vivo.
RESEARCH
The Scharenberg laboratory is focused on the development of technology for engineering T-cells and hematopoetic stem cells:
1. Gene editing methods and technology: Our present efforts are centered on optimizing gene editing efficiency in primary T-cells and hematopoietic stem cells using viral vectors and advanced electroporation methods, and on developing gene edited cell products for hematopoietic genetic diseases and tolerance applications.
2. Synthetic biology: Next generation cell therapies require new approaches to provide physician control over cell survival, expansion, and potency. We are working on developing orthogonal receptor signaling systems that can be embedded in gene edited cell products to enable precise control over these characteristics.
3. Vector biology: we are working on developing synthetic vector systems for delivery of gene therapy and gene editing components both ex vivo and in vivo.
研究兴趣
论文共 252 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
A. Yingst,D. Vereide, D. Jarrell,R. Koning, C. Arnold, A. Romanov, M. Murphy,R. Crisman, R.P. Larson, B. Salinas,A. Scharenberg, S. O'Hara
Cytotherapyno. 6 (2024): S17
Christopher J. Nicolai, Maura Parker,Jim Qin, Weiliang Tang, Justin Ulrich-Lewis, Rebecca J. Gottschalk, Sara Cooper,Susana Hernandez,Don Parrilla, Richard Mangio, Nolan Ericson,Alissa Brandes,
Blood (2024)
MOLECULAR THERAPYno. 4 (2023): 99-100
引用0浏览0引用
0
0
CANCER RESEARCHno. 7 (2023)
Peter J. Cook,Su Jung Yang, Gene I. Uenishi, Annaiz Grimm,Samuel E. West,Li-Jie Wang, Chester Jacobs, Andrea Repele, Travis Drow, Ahmad Boukhris,Noelle P. Dahl, Karen Sommer,
Molecular therapy : the journal of the American Society of Gene Therapyno. 8 (2023): 2472-2488
crossref(2023)
Alyssa Sheih, Nanda Coelho,Kathryn Michels,Anna Ting,Susana H. Lopez,Kelsey Lynch,Kristen Mittelsteadt, Ruth Chenault,Alissa Brandes,Don Parrilla,Anai M. Perez,Mason Muhonen,
MOLECULAR THERAPYno. 4 (2023): 27-28
引用0浏览0引用
0
0
Maura Parker, Justin Ulrich-Lewis, Weiliang Tang,Chris Nicolai,Kathryn Michels,Susana Hernandez,Don Parrilla, Sara Cooper,Anai Perez,Mollie McDonnell,Greyson Hamilton,Chang-Chih Wu,
Blood (2023): 765
crossref(2023)
加载更多
作者统计
#Papers: 0
#Citation: 0
H-Index: 0
G-Index: 0
Sociability: 0
Diversity: 0
Activity: 0
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn